BDBM511708 (3S)-5-(2-azaspiro[3.3]heptan-2-ylmethyl)-2- (2-(3-acetyl-5-(2-methylpyrimidin-5-yl)-1H- indazol-1-yl)acetyl)-N-(6-bromo-3- methylpyridin-2-yl)-2- azabicyclo[3.1.0]hexane-3-carboxamide::US11084800, Cpd No. 13::US11708351, Compound 13

SMILES CC(=O)c1nn(CC(=O)N2C3CC3(CN3CC4(CCC4)C3)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2ccc(cc12)-c1cnc(C)nc1

InChI Key InChIKey=ADQXQROJYUUIGO-MZJJXFGQSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 511708   

TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM511708((3S)-5-(2-azaspiro[3.3]heptan-2-ylmethyl)-2- (2-(3...)
Affinity DataIC50: <1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM511708((3S)-5-(2-azaspiro[3.3]heptan-2-ylmethyl)-2- (2-(3...)
Affinity DataIC50: <1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent